Literature DB >> 34385696

Control of the activity of CAR-T cells within tumours via focused ultrasound.

Yiqian Wu1,2, Yahan Liu2,3, Ziliang Huang2, Xin Wang1, Zhen Jin4, Jiayi Li1, Praopim Limsakul5, Linshan Zhu1, Molly Allen1, Yijia Pan1, Robert Bussell6, Aaron Jacobson6, Thomas Liu6, Shu Chien7,8, Yingxiao Wang9,10.   

Abstract

Focused ultrasound can deliver energy safely and non-invasively into tissues at depths of centimetres. Here we show that the genetics and cellular functions of chimeric antigen receptor T cells (CAR-T cells) within tumours can be reversibly controlled by the heat generated by short pulses of focused ultrasound via a CAR cassette under the control of a promoter for the heat-shock protein. In mice with subcutaneous tumours, locally injected T cells with the inducible CAR and activated via focused ultrasound guided by magnetic resonance imaging mitigated on-target off-tumour activity and enhanced the suppression of tumour growth, compared with the performance of non-inducible CAR-T cells. Acoustogenetic control of the activation of engineered T cells may facilitate the design of safer cell therapies.
© 2021. The Author(s), under exclusive licence to Springer Nature Limited.

Entities:  

Mesh:

Year:  2021        PMID: 34385696      PMCID: PMC9015817          DOI: 10.1038/s41551-021-00779-w

Source DB:  PubMed          Journal:  Nat Biomed Eng        ISSN: 2157-846X            Impact factor:   29.234


  43 in total

Review 1.  Antibody-modified T cells: CARs take the front seat for hematologic malignancies.

Authors:  Marcela V Maus; Stephan A Grupp; David L Porter; Carl H June
Journal:  Blood       Date:  2014-02-27       Impact factor: 22.113

2.  A multifunctional AAV-CRISPR-Cas9 and its host response.

Authors:  Wei Leong Chew; Mohammadsharif Tabebordbar; Jason K W Cheng; Prashant Mali; Elizabeth Y Wu; Alex H M Ng; Kexian Zhu; Amy J Wagers; George M Church
Journal:  Nat Methods       Date:  2016-09-05       Impact factor: 28.547

3.  Regional Delivery of Chimeric Antigen Receptor-Engineered T Cells Effectively Targets HER2+ Breast Cancer Metastasis to the Brain.

Authors:  Saul J Priceman; Dileshni Tilakawardane; Brook Jeang; Brenda Aguilar; John P Murad; Anthony K Park; Wen-Chung Chang; Julie R Ostberg; Josh Neman; Rahul Jandial; Jana Portnow; Stephen J Forman; Christine E Brown
Journal:  Clin Cancer Res       Date:  2017-10-23       Impact factor: 12.531

Review 4.  Synthetic biology in cell-based cancer immunotherapy.

Authors:  Deboki Chakravarti; Wilson W Wong
Journal:  Trends Biotechnol       Date:  2015-06-16       Impact factor: 19.536

5.  Active Surveillance for Intermediate Risk Prostate Cancer: Survival Outcomes in the Sunnybrook Experience.

Authors:  Hima Bindu Musunuru; Toshihiro Yamamoto; Laurence Klotz; Gabriella Ghanem; Alexandre Mamedov; Peraka Sethukavalan; Vibhuti Jethava; Suneil Jain; Liying Zhang; Danny Vesprini; Andrew Loblaw
Journal:  J Urol       Date:  2016-08-26       Impact factor: 7.450

6.  Locoregional delivery of CAR T cells to the cerebrospinal fluid for treatment of metastatic medulloblastoma and ependymoma.

Authors:  Laura K Donovan; Alberto Delaidelli; Sujith K Joseph; Kevin Bielamowicz; Kristen Fousek; Borja L Holgado; Alex Manno; Dilakshan Srikanthan; Ahmed Z Gad; Randy Van Ommeren; David Przelicki; Cory Richman; Vijay Ramaswamy; Craig Daniels; Jonelle G Pallota; Tajana Douglas; Alyssa C M Joynt; Joonas Haapasalo; Carolina Nor; Maria C Vladoiu; Claudia M Kuzan-Fischer; Livia Garzia; Stephen C Mack; Srinidhi Varadharajan; Matthew L Baker; Liam Hendrikse; Michelle Ly; Kaitlin Kharas; Polina Balin; Xiaochong Wu; Lei Qin; Ning Huang; Ana Guerreiro Stucklin; A Sorana Morrissy; Florence M G Cavalli; Betty Luu; Raul Suarez; Pasqualino De Antonellis; Antony Michealraj; Avesta Rastan; Meenakshi Hegde; Martin Komosa; Olga Sirbu; Sachin A Kumar; Zied Abdullaev; Claudia C Faria; Stephen Yip; Juliette Hukin; Uri Tabori; Cynthia Hawkins; Ken Aldape; Mads Daugaard; John M Maris; Poul H Sorensen; Nabil Ahmed; Michael D Taylor
Journal:  Nat Med       Date:  2020-04-27       Impact factor: 53.440

Review 7.  Regional Delivery of Chimeric Antigen Receptor (CAR) T-Cells for Cancer Therapy.

Authors:  Praveen Sridhar; Fabio Petrocca
Journal:  Cancers (Basel)       Date:  2017-07-18       Impact factor: 6.639

Review 8.  CAR T Cells for Solid Tumors: New Strategies for Finding, Infiltrating, and Surviving in the Tumor Microenvironment.

Authors:  Marina Martinez; Edmund Kyung Moon
Journal:  Front Immunol       Date:  2019-02-05       Impact factor: 7.561

9.  Monitoring of the central blood pressure waveform via a conformal ultrasonic device.

Authors:  Chonghe Wang; Xiaoshi Li; Hongjie Hu; Lin Zhang; Zhenlong Huang; Muyang Lin; Zhuorui Zhang; Zhenan Yin; Brady Huang; Hua Gong; Shubha Bhaskaran; Yue Gu; Mitsutoshi Makihata; Yuxuan Guo; Yusheng Lei; Yimu Chen; Chunfeng Wang; Yang Li; Tianjiao Zhang; Zeyu Chen; Albert P Pisano; Liangfang Zhang; Qifa Zhou; Sheng Xu
Journal:  Nat Biomed Eng       Date:  2018-09-11       Impact factor: 25.671

10.  Engineering T Cells with Customized Therapeutic Response Programs Using Synthetic Notch Receptors.

Authors:  Kole T Roybal; Jasper Z Williams; Leonardo Morsut; Levi J Rupp; Isabel Kolinko; Joseph H Choe; Whitney J Walker; Krista A McNally; Wendell A Lim
Journal:  Cell       Date:  2016-09-29       Impact factor: 41.582

View more
  13 in total

Review 1.  Towards controlled drug delivery in brain tumors with microbubble-enhanced focused ultrasound.

Authors:  Scott Schoen; M Sait Kilinc; Hohyun Lee; Yutong Guo; F Levent Degertekin; Graeme F Woodworth; Costas Arvanitis
Journal:  Adv Drug Deliv Rev       Date:  2021-11-18       Impact factor: 15.470

Review 2.  The roles of thermal and mechanical stress in focused ultrasound-mediated immunomodulation and immunotherapy for central nervous system tumors.

Authors:  Chulyong Kim; Michael Lim; Graeme F Woodworth; Costas D Arvanitis
Journal:  J Neurooncol       Date:  2022-03-02       Impact factor: 4.506

Review 3.  The evolution of synthetic receptor systems.

Authors:  Janvie Manhas; Hailey I Edelstein; Joshua N Leonard; Leonardo Morsut
Journal:  Nat Chem Biol       Date:  2022-01-20       Impact factor: 16.174

Review 4.  Engineering CAR T cells for enhanced efficacy and safety.

Authors:  Yiqian Wu; Ziliang Huang; Reed Harrison; Longwei Liu; Linshan Zhu; Yinglin Situ; Yingxiao Wang
Journal:  APL Bioeng       Date:  2022-01-18

Review 5.  Chimeric Antigen Receptor T-Cell Therapy in Lung Cancer: Potential and Challenges.

Authors:  Bu-Fan Xiao; Jing-Tao Zhang; Yu-Ge Zhu; Xin-Run Cui; Zhe-Ming Lu; Ben-Tong Yu; Nan Wu
Journal:  Front Immunol       Date:  2021-11-01       Impact factor: 7.561

Review 6.  CAR T Cell Therapy in Primary Brain Tumors: Current Investigations and the Future.

Authors:  Ya-Jui Lin; Leila A Mashouf; Michael Lim
Journal:  Front Immunol       Date:  2022-02-21       Impact factor: 7.561

Review 7.  Special Chimeric Antigen Receptor (CAR) Modifications of T Cells: A Review.

Authors:  Lele Miao; Juan Zhang; Binjie Huang; Zhengchao Zhang; Song Wang; Futian Tang; Muzhou Teng; Yumin Li
Journal:  Front Oncol       Date:  2022-03-22       Impact factor: 6.244

Review 8.  Synergetic Thermal Therapy for Cancer: State-of-the-Art and the Future.

Authors:  Qizheng Dai; Bo Cao; Shiqing Zhao; Aili Zhang
Journal:  Bioengineering (Basel)       Date:  2022-09-15

9.  Nano-optogenetic immunotherapy.

Authors:  Kai Huang; Xiaoxuan Liu; Gang Han; Yubin Zhou
Journal:  Clin Transl Med       Date:  2022-09

10.  Spatiotemporal control of engineered bacteria to express interferon-γ by focused ultrasound for tumor immunotherapy.

Authors:  Yuhao Chen; Meng Du; Zhen Yuan; Zhiyi Chen; Fei Yan
Journal:  Nat Commun       Date:  2022-08-02       Impact factor: 17.694

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.